Flavio Aliberti

  https://medium.com/@flavalib Flavio Aliberti brings with him a 23-year track record in consulting around business intelligence, change management, strategy, M&A transformation, IT and SOX auditing for high regulated domains, like Insurance, Airlines, Trade Associations, Automotive, and Pharma. He holds an MSc in Space Aeronautic Engineering from the University of Naples and an MSc in Advanced Information Technology and Business Management from the University of Wales.

 



78 Stories by Flavio Aliberti

The Persistent Failure Of Merger and Acquisition deals and why

M&A is not about transforming a company. It is about understanding what stays the same while everything else changes. Every day, we hear about a...
3 min read 669

Essential Strategy For Big Data

Machines complement humans. Data is multifaceted, and making sense of it demands a fresh approach with ancient roots “Mega biblia, mega kakon” (Big books, big...
2 min read 255

Beyond drugs: the importance of wearables in life sciences

Increasingly specialized, life science organizations have lost the compass. Digital can improve lives if they look at digital innovation in in its broadest sense “Knowing...
4 min read 267

The Cloud is More than Streamlining Operation

Many associate cloud migration with IT. Few realize the cloud delivers more than cost savings and compliance. There is usually a specific event or...
3 min read 159

Why Cloud Is Smart For Mergers And Acquisitions

Mergers and acquisitions present a unique opportunity to implement digital change, and shifting to the cloud can greatly improve benefits. Increasing the value of...
2 min read 294

Beyond Industry 4.0, Digital Will Reshape Our Society

Firms that use digital technologies only to execute tasks more cost-effectively may miss the unique opportunity to rethink themselves around evolving society. A digital transformation...
4 min read 280

Supply Chain Planning and Clinical Trials Adaptive Design

It is time for cheaper, faster, more granular, and more precise clinical trials Discovering new drugs, repurposing or repositioning existing ones, and reducing healthcare costs...
2 min read 170

Repurposing drugs: a missed opportunity

Key principles and suggestions to foster collaboration and unleash the potential of repurposing drugs, for more equal and accessible healthcare. We can’t learn, be...
4 min read 142

A Journey to Self-Sufficiency

It is time to reconsider how we think about sustainability and incorporate it into all aspects of our consumption, manufacturing, innovation, and design. The...
4 min read 234

Who should lead the digital agenda?

Time is ticking away. The digital pace is accelerating and many organizations are behind schedule with their digital agenda. Their plan includes actions ranging...
2 min read 386

Is Life Science industry healthy?

“Shoemaker’s son always goes barefoot“ Anyone reading the news about Life Science companies would believe that everything is OK for them, with billions of...
3 min read 336

What to consider for an IT Vendor Strategy? Wrong choices of today put future at risk

The new IT organizations’ mantra is to be agile, disruptive, digital. Responding to that, consulting firms and system integrators have all adjusted their offering...
2 min read 338